Literature DB >> 25853301

Albumin: the next-generation delivery technology.

Kenneth A Howard.   

Abstract

Keywords:  albumin; albumin fusions; albumin-binding; half-life extension; human serum albumin; intracellular delivery; neonatal Fc receptor (FcRn); recombinant albumin; targeted drug- delivery

Mesh：

Substances：

Year:  2015        PMID： 25853301     DOI： 10.4155/tde.14.124

Source DB:  PubMed          Journal:  Ther Deliv        ISSN： 2041-5990


× No keyword cloud information.
  6 in total

1.  Protein modification by thiolactone homocysteine chemistry: a multifunctionalized human serum albumin theranostic.

Authors:  Tatyana V Popova; Olesya A Krumkacheva; Anna S Burmakova; Anna S Spitsyna; Olga D Zakharova; Vladimir A Lisitskiy; Igor A Kirilyuk; Vladimir N Silnikov; Michael K Bowman; Elena G Bagryanskaya; Tatyana S Godovikova
Journal:  RSC Med Chem       Date:  2020-04-02

2.  Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation.

Authors:  Michael Lykke Hvam; Yunpeng Cai; Frederik Dagnæs-Hansen; Jesper Sejrup Nielsen; Jesper Wengel; Jørgen Kjems; Kenneth A Howard
Journal:  Mol Ther       Date:  2017-06-20       Impact factor: 11.454

3.  Modified norcyanines enable ratiometric pH imaging beyond 1000 nm.

Authors:  Syed Muhammad Usama; Donald R Caldwell; Pradeep Shrestha; Michael P Luciano; Nimit L Patel; Joseph D Kalen; Joseph Ivanic; Martin J Schnermann
Journal:  Biosens Bioelectron       Date:  2022-08-02       Impact factor: 12.545

4.  A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation.

Authors:  Karen Kræmmer Schelde; Karl Nicholls; Frederik Dagnæs-Hansen; Karen Bunting; Helen Rawsthorne; Birgitte Andersen; Christopher J A Finnis; Miranda Williamson; Jason Cameron; Kenneth A Howard
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

5.  A self-assembled, modular nucleic acid-based nanoscaffold for multivalent theranostic medicine.

Authors:  Veronica Liv Andersen; Mathias Vinther; Rajesh Kumar; Annika Ries; Jesper Wengel; Jesper Sejrup Nielsen; Jørgen Kjems
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

6.  An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications.

Authors:  Matthias Kuhlmann; Jonas B R Hamming; Anders Voldum; Georgia Tsakiridou; Maja T Larsen; Julie S Schmøkel; Emil Sohn; Konrad Bienk; David Schaffert; Esben S Sørensen; Jesper Wengel; Daniel M Dupont; Kenneth A Howard
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.